Kyle W. Gheres

Kyle is responsible for managing Actuated’s Neural Devices R&D programs as well as commercial activities of the NeuralGlider Inserter, which uses ultrasonic micro-vibration to reduce forces and resultant dimpling during neural implant insertions. Currently, he manages preclinical research studies with partnering investigators at Carnegie Mellon University, the University of Pittsburgh, the University of North Carolina, Penn State University, and others. Actuated’s active neuroscience research programs also include the development of surgical tools for peripheral nerve electrode and deep brain stimulation electrode implantation, as well as therapeutic ultrasound technologies for neural applications. Kyle earned his B.S. in Biochemistry and Molecular Biology from Penn State University as well as his Ph.D. in Molecular Cellular and Integrative Biosciences.